European Association for the Study of Diabetes

The latest news from the EASD Annual Meeting, with physician perspective, researcher interviews and clinician insight.

Meeting News

Prediabetes, diabetes comorbidities differ among children, women, men

September 17, 2019
In large cohort of individuals assessed for prediabetes and diabetes, prediabetes was identified in 4.6% of children and distinct cardiometabolic…
Meeting NewsPerspective

Obesity increases diabetes risk independent of genetics, lifestyle habits

September 16, 2019
A person with obesity is nearly six times more likely to develop type 2 diabetes over a decade when compared with a person of normal weight…
Meeting News

Top stories from EASD 2018

October 19, 2018
The 54th annual meeting of the European Association for the Study of Diabetes was held earlier this month, and Endocrine Today covered the latest…
Meeting NewsPerspective

CARMELINA: Linagliptin safe, effective in type 2 diabetes with CVD, kidney disease

October 8, 2018
Among adults with type 2 diabetes, established cardiovascular disease and/or chronic kidney disease, the DPP-IV inhibitor linagliptin demonstrated CV…
Meeting NewsPerspective

Leading diabetes groups stress patient-centered care, new therapies in updated consensus report

October 5, 2018
Providers should prioritize patient-centered care for type 2 diabetes that incorporates therapy regimens tailored to specific patient goals, whereas…
Meeting NewsPerspective

Lorcaserin reduces diabetes progression in high-risk adults with obesity, CVD

October 5, 2018
Adults with obesity, prediabetes and established cardiovascular disease randomly assigned to the serotonin receptor agonist lorcaserin were less…
Meeting News

Artificial pancreas improves time-in-range glucose values vs. pump therapy

October 3, 2018
A cohort of patients with type 1 diabetes, including children as young as age 6 years, treated with insulin pump therapy experienced a 10%…
Meeting News

ELIXA: Lixisenatide slows, reduces macroalbuminuria risk in type 2 diabetes with CVD

October 3, 2018
Adults with type 2 diabetes, established cardiovascular disease and macroalbuminuria assigned to the GLP-1 receptor agonist lixisenatide experienced…
Meeting NewsPerspective

HARMONY: Albiglutide reduces CV risk in adults with type 2 diabetes, CVD

October 3, 2018
Adults with type 2 diabetes and atherosclerotic disease randomly assigned to the once-weekly GLP-1 receptor agonist albiglutide experienced a 22%…
Meeting NewsPerspective

Dementia increases risk for death from hypoglycemia in older adults with diabetes

October 2, 2018
Older adults with diabetes and dementia were 67% more likely to die vs. those with diabetes but without dementia, according to findings presented at…